Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial Academic Article Article uri icon

Overview

MeSH Major

  • Masked Hypertension

abstract

  • No additional benefit of slowing progression of hypertensive nephrosclerosis was observed with the lower BP goal. Angiotensin-converting enzyme inhibitors appear to be more effective than beta-blockers or dihydropyridine calcium channel blockers in slowing GFR decline.

publication date

  • November 20, 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1001/jama.288.19.2421

PubMed ID

  • 12435255

Additional Document Info

start page

  • 2421

end page

  • 31

volume

  • 288

number

  • 19